In vitro activity of aztreonam in combination with relebactam against gram-negative pathogens producing various serine and metallo-β-lactamases
Kengo Hayashi(Fujita Health University), Yohei Doi(Fujita Health University), Kazuaki Matsumoto(Keio University), Sho Saito(National Center for Global Health and Medicine), Yoshikazu Ishii(Toho University), Masahiro Suzuki(Fujita Health University), Yasufumi Matsumura(Kyoto University)
Cited by 1
Related Papers
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
|The Lancet Infectious Diseases|2017|521
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
|The Lancet Infectious Diseases|2021|338
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
|The Lancet Infectious Diseases|2020|328
Cloning of a Novel Gene for Quinolone Resistance from a Transferable Plasmid in <i>Shigella flexneri</i> 2b
|Antimicrobial Agents and Chemotherapy|2005|290